Global Patent Index - EP 3310168 A4

EP 3310168 A4 20190306 - METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS

Title (en)

METHODS AND COMPOSITIONS FOR TREATING HERPESVIRUS INDUCED CONDITIONS

Title (de)

VERFAHREN UND ZUSAMMENSETZUNGEN ZUR BEHANDLUNG VON HERPESVIRUS-INDUZIERTEN ZUSTÄNDEN

Title (fr)

PROCÉDÉS ET COMPOSITIONS PERMETTANT DE TRAITER DES ÉTATS INDUITS PAR LE VIRUS HERPÉTIQUE

Publication

EP 3310168 A4 20190306 (EN)

Application

EP 16812548 A 20160617

Priority

  • US 201562182071 P 20150619
  • US 2016038148 W 20160617

Abstract (en)

[origin: WO2016205695A1] Provided are methods and compositions for the prevention and/or treatment of viral conditions, virally-induced conditions and inflammatory conditions. The methods can comprise administering to a subject a viral inducing agent with an antiviral agent, and optionally an additional agent. The viral inducing agent can be a HDAC inhibitor administered orally. The HDAC inhibitor can be chidamide or 4SC-202.

IPC 8 full level

A61K 31/4406 (2006.01); A61K 31/4155 (2006.01); A61K 31/522 (2006.01); A61K 45/06 (2006.01); A61P 29/00 (2006.01); A61P 31/22 (2006.01); A61P 35/00 (2006.01); A61P 37/02 (2006.01)

CPC (source: EP US)

A61K 31/4155 (2013.01 - EP US); A61K 31/4406 (2013.01 - EP US); A61K 31/522 (2013.01 - EP US); A61K 45/06 (2013.01 - EP US); A61P 29/00 (2018.01 - EP US); A61P 31/22 (2018.01 - EP US); A61P 35/00 (2018.01 - EP US); A61P 37/02 (2018.01 - EP US); A61K 2300/00 (2013.01 - US)

C-Set (source: EP US)

  1. A61K 31/4155 + A61K 2300/00
  2. A61K 31/4406 + A61K 2300/00
  3. A61K 31/522 + A61K 2300/00

Citation (search report)

  • [Y] US 2013331313 A1 20131212 - BERENSON RONALD J [US], et al
  • [Y] CN 104083763 A 20141008 - INST TRANSFUSION MEDICINE ACADEMY MILITARY MEDICAL SCIENCES
  • [Y] US 2014170221 A1 20140619 - IRVINE DARRELL J [US], et al
  • [Y] SAJAL K GHOSH ET AL: "Histone deacetylase inhibitors are potent inducers of gene expression in latent EBV and sensitize lymphoma cells to nucleoside antiviral agents", BLOOD, 7 December 2011 (2011-12-07), pages 1008 - 1017, XP055548340, Retrieved from the Internet <URL:http://www.bloodjournal.org/content/bloodjournal/119/4/1008.full.pdf> [retrieved on 20190128], DOI: 10.1182/blood-2011-06-
  • See also references of WO 2016205695A1

Designated contracting state (EPC)

AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DOCDB simple family (publication)

WO 2016205695 A1 20161222; CN 108347929 A 20180731; CN 116712552 A 20230908; EP 3310168 A1 20180425; EP 3310168 A4 20190306; HK 1254168 A1 20190712; JP 2018517757 A 20180705; JP 2022058416 A 20220412; JP 7366385 B2 20231023; US 2018185345 A1 20180705; US 2021046061 A1 20210218; US 2024041848 A1 20240208

DOCDB simple family (application)

US 2016038148 W 20160617; CN 201680046420 A 20160617; CN 202310699709 A 20160617; EP 16812548 A 20160617; HK 18113305 A 20181017; JP 2017565967 A 20160617; JP 2021211486 A 20211224; US 201615737701 A 20160617; US 202016835122 A 20200330; US 202318206947 A 20230607